Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
bromfenac (xibrom) (1 trial)
nepafenac (nevanac) (1 trial)
ot-101 (1 trial)
si-614 (1 trial)
dupilumab (dupixent) (1 trial)
kb-gdt-01 (1 trial)
Cataract (Phase 4)
Inflammation (Phase 4)
Keratoconjunctivitis (Phase 2)
Trials (5 total)
Trial APIs (6 total)